Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Monday, August 11, 2014

New Podcast and White Paper on the Pain Market

Podcast: Pharma Attempts to Ease the Pain

Thought Leader: Michael Fronstin, General Manager, Health Outcomes, Forecasting and Epidemiology, Kantar Health

In this episode, Mr. Fronstin illustrates the size and scope of the pain market, addresses current unmet needs, outlines promising new Mechanisms of Action, and covers the implications for the pharma industry.

Michael Fronstin
Play podcast

Download transcript of podcast

White Paper: The Pain Market and the Promise of New Mechanisms of Action

This white paper explores the current drug development landscape of the pain market and the most promising mechanisms of action in development. It identifies the pain conditions new drugs most commonly targeted for development focus on. Lastly, it covers the commercial implications for manufacturers.

Download white paper

PharmaVOICE

2 comments:

ilayda said...

siirt
van
hakkari
kastamonu
kütahya

4003

melis said...

karşıyaka transfer
akbük transfer
balıkesir transfer
ayvalık transfer
aliağa transfer

L4JKV

Post a Comment